Marshall Wace
STAA icon

Marshall Wace’s STAAR Surgical STAA Stock Holding History

Marshall Wace’s Portfolio STAA Stock Details STAA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$214K Sell
11,449
-289,134
-96% -$5.52M ﹤0.01% 2768
2025
Q4 		$6.94M Buy
300,583
+173,310
+136% +$4.47M 0.01% 1013
2025
Q3 		$3.42M Buy
+127,273
New +$3.03M ﹤0.01% 1356
2025
Q1 		– Sell
-152,553
Closed -$3.71M – 3071
2024
Q4 		$3.71M Sell
152,553
-192,023
-56% -$5.48M ﹤0.01% 1190
2024
Q3 		$12.8M Buy
344,576
+164,872
+92% +$6.15M 0.02% 667
2024
Q2 		$8.56M Sell
179,704
-28,293
-14% -$1.24M 0.01% 803
2024
Q1 		$7.96M Buy
207,997
+43,377
+26% +$1.41M 0.01% 828
2023
Q4 		$5.14M Buy
164,620
+131,120
+391% +$4.71M 0.01% 903
2023
Q3 		$1.35M Buy
33,500
+29,000
+644% +$1.36M ﹤0.01% 1389
2023
Q2 		$237K Buy
4,500
+600
+15% +$36.5K ﹤0.01% 2203
2023
Q1 		$249K Sell
3,900
-2,700
-41% -$176K ﹤0.01% 2352
2022
Q4 		$320K Buy
+6,600
New +$414K ﹤0.01% 2542
2022
Q1 		– Sell
-2,485
Closed -$226K – 3984
2021
Q4 		$226K Buy
+2,485
New +$267K ﹤0.01% 3116
2020
Q2 		– Sell
-252,077
Closed -$8.13M – 1921
2020
Q1 		$8.13M Buy
252,077
+205,724
+444% +$6.93M 0.08% 253
2019
Q4 		$1.63M Sell
46,353
-327,055
-88% -$10.8M 0.01% 863
2019
Q3 		$9.63M Sell
373,408
-164,746
-31% -$5.01M 0.08% 308
2019
Q2 		$15.8M Buy
538,154
+336,624
+167% +$9.72M 0.13% 181
2019
Q1 		$6.89M Buy
201,530
+49,363
+32% +$1.75M 0.06% 368
2018
Q4 		$4.86M Sell
152,167
-26,303
-15% -$1.02M 0.05% 449
2018
Q3 		$8.57M Buy
+178,470
New +$7.31M 0.07% 332

Other funds holding STAA

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
YC
Yunqi Capital Hong Kong $92.4M AUM 16.3% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AIM
Anatole Investment Management Central, Hong Kong $716M AUM 502.49% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Marshall Wace's STAA Position: Q1 2026 in Review

Marshall Wace reduced its STAAR Surgical (STAA) stake by 96% in Q1 2026, selling an estimated $5.52M and leaving 11,449 shares worth $214K. The position accounts for ﹤0.01% of the portfolio, ranked #2768.

Marshall Wace first reported a position in STAA in Q3 2018 and has held it in 20 quarters since. The position peaked at $15.8M in Q2 2019. 187 funds tracked by Wall St. Rank hold STAA as of Q1 2026.

  • Marshall Wace held 11,449 shares of STAAR Surgical worth $214K as of Q1 2026.
  • Marshall Wace sold 289,134 STAAR Surgical shares in Q1 2026, an estimated $5.52M.
  • STAAR Surgical made up ﹤0.01% of Marshall Wace's portfolio in Q1 2026, its #2768 holding.
  • Marshall Wace first reported a position in STAAR Surgical in Q3 2018 and has held it in 20 quarters since.
  • Marshall Wace's STAAR Surgical position peaked at $15.8M in Q2 2019.
  • 187 funds tracked by Wall St. Rank held STAAR Surgical as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.